IPSEY (IPSEY) Stock Price & Analysis
IPSEY (IPSEY) fell 3.60% to USD 42.27 as of June 10, 2026 at 00:49 UTC, according to Nexqual real-time market data.
IPSEY last closed at USD 43.85; the session ranged USD 42.27–42.64 on volume of 94 shares. Market capitalization is $13.93B, with a 52-week range of USD 28.66–51.1 (PNK). Source: Nexqual, June 10, 2026 at 00:49 UTC.
Key Statistics (as of June 10, 2026 at 00:49 UTC)
| Price | USD 42.27 |
|---|---|
| Change | ▼ 3.60% (down) |
| Previous Close | USD 43.85 |
| Open | USD 42.64 |
| Day Range | USD 42.27 – 42.64 |
| 52-Week Range | USD 28.66 – 51.1 |
| Volume | 94 shares |
| Market Cap | $13.93B |
| Exchange | PNK |
Technical Analysis (IPSEY)
Nexqual's technical model rates IPSEY "SELL" based on 1 bullish and 4 bearish signals across 123 daily candles, as of June 10, 2026 at 00:49 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 49.08 (neutral) |
| vs SMA50 | Below (USD 47.89) |
| MACD | -0.91 (negative) |
Analyst Ratings (IPSEY)
Wall Street analysts rate IPSEY "None", per Nexqual as of June 10, 2026 at 00:49 UTC.
| Consensus Rating | None |
|---|
Earnings (IPSEY)
Source: Nexqual, June 10, 2026 at 00:49 UTC.
Financials & Fundamentals (IPSEY)
| Total Revenue | $3.93B |
|---|---|
| Revenue Growth (YoY) | +9.30% |
| Gross Margin | +80.89% |
| Operating Margin | +26.10% |
| Profit Margin | +11.29% |
| ROE | +10.44% |
| Debt / Equity | 22.38 |
| Current Ratio | 1.96 |
| Total Cash | $1.53B |
| Total Debt | $970.40M |
| Free Cash Flow | $651.95M |
Source: Nexqual, June 10, 2026 at 00:49 UTC.
Financial Health Score (IPSEY)
Nexqual rates IPSEY's overall financial health "Strong" across five dimensions, as of June 10, 2026 at 00:49 UTC.
| Growth | Strong — Revenue +16% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 81%, operating 26% |
| Balance Sheet | Strong — $1.53B cash vs $970M debt, net cash position |
| Cash Flow | Strong — FCF $652M, 17% margin |
| Efficiency | Mixed — ROE 10%, ROA 9.6% |
Ownership (IPSEY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 329.64M |
| Float | 120.45M |
Source: Nexqual, June 10, 2026 at 00:49 UTC.
Leadership (IPSEY)
IPSEY is led by David Loew (age 58), MD, CEO & Director, per Nexqual as of June 10, 2026 at 00:49 UTC.
| MD, CEO & Director | David Loew (age 58) |
|---|---|
| Executive VP & CFO | Aymeric Le Chatelier (age 56) |
| Executive Vice President of Technical Operations | Pierrick Lefranc |
| Global Vice President of Investor Relations | Henry Wheeler M.Sc. (age 41) |
| Executive VP, Chief Product Officer & Head of GPPS | Mari Scheiffele |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SGIOY | Shionogi & Co. Ltd. | USD 8.56 | ▼ 2.28% |
| MKKGY | Merck KGaA | USD 32 | ▲ 2.11% |
| UCBJY | UCB S.A. | USD 151.74 | ▲ 1.47% |
| OPHLY | Ono Pharmaceutical Co., Ltd. | USD 4.56 | ▲ 0.22% |
| OTSKY | Otsuka Holdings Co. Ltd. | USD 31.86 | ▼ 2.03% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:49 UTC. This page is informational and not investment advice.